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TO THE EDITOR
Olmsted syndrome (OS) is a very rare,
severe keratinization disorder charac-
terized by a combination of bilateral
mutilating palmoplantar keratoderma
and periorificial keratotic plaques
(Olmsted, 1927). The other associated
features reported include corneal le-
sions, diffuse alopecia, digital constric-
tion, nail dystrophy, high-tone loss of
hearing, infections, and squamous cell
carcinomas (Mevorah et al., 2005).
Clinical management of OS includes
topical keratolytics, surgical removal of
the keratotic palmoplantar masses fol-
lowed by autograft, and use of systemic
retinoids with variable results (Mevorah
et al., 2005). A total of 54 cases of OS
have been reported worldwide in the
literature, of which only 12 cases were
familial (Lin et al., 2012; Tang et al.,
2012) with different modes of inheri-
tance (Cambiaghi et al., 1995; Larregue
et al., 2000; Lin et al., 2012).
Recently, gain-of-function mutations
in the transient receptor potential va-
nilloid 3 gene (TRPV3) were identified
as a cause of autosomal dominant
OS in five sporadic and one familial
case (Lin et al., 2012). It is hypothesized
that OS-associated TRPV3 mutations
cause deregulated TRPV3 channel
activity in keratinocytes (Lin et al.,
2012). However, the genetic basis of
X-linked forms of OS has not been
elucidated.
Using whole-exome sequencing
(Supplementary Materials online, Mate-
rials and Methods and Supplementary
Table S1 online), we investigated the
genetic basis of OS in a consangui-
neous extended kindred, in which the
disease followed a pattern of X-linked
recessive inheritance (Figure 1a). The
female family members (I-1 and II-2) do
not exhibit any clinical features of OS.
The minimum diagnostic criteria for
OS were periorificial keratotic plaques
and bilateral palmoplantar transgre-
dient keratoderma (Bergonse et al.,
2003). The probands did not have
features specific to BRESEK/BRESHECK
syndrome such as hearing loss,
skeletal abnormalities, or dysmorphic
features.
The male probands were an uncle
(II-1) and nephew (III-2) (Figure 1a). The
patients were born to healthy consan-
guineous parents after uneventful and
full-term pregnancies. The clinical fea-
tures for these patients have been
described in detail previously (Yaghoobi
et al., 2007). In brief, II-1 presented with
alopecia universalis and hyperkeratotic
lesions, especially around his body
orifices and palmoplantar areas at the
age of 6 months. Examination revealed
severe periorificial plaques around the
mouth and perianal regions. The mas-
sive hyperkeratosis with painful deep
fissures had resulted in flexion contrac-
ture and inability to extend the joints.
The lesions were yellowish-brown,
pruritic, painful, and in some areas
associated with malodor or infection.
The nails, which were hyperkeratotic
and severely dystrophic, had a fork-like
appearance and were yellow in colour.
Subungual hyperkeratosis was present
(Figure 1b and d). The nephew of the
proband (III-2) had similar patterns of
disease onset and clinical features.
Further clinical information can be
found in the Supplementary Materials
online, Clinical Information on the
Probands II-1 and III-2.
Exome sequencing revealed a muta-
tion, which to our knowledge is
previously unreported: c.1391T4C
(p.F464S) in exon 11 of the X-chromo-
some gene membrane-bound transcrip-
tion factor protease, site 2 (MBTPS2)
(NM_015884.3) in both male probands
(Figure 2a). This mutation results in the
substitution of the highly conserved
phenylalanine residue at codon 464
(Figure 2b) by a serine, which Poly-
Phen-2 (http://genetics.bwh.harvard.
edu/pph2/) predicts would be probably
damaging (score¼ 0.994). This muta-
tion is not present in online databases
dbSNP (http://www.ncbi.nlm.nih.gov/
projects/SNP/), 1000 Genomes (http://
www.1000genomes.org/), NHLBI exome
sequencing project (http://evs.gs.wa-
shington. edu/EVS/), or the MBTPS2 gene
variant database (http://www.LOVD.nl/
MBTPS2). Genetic screening of other
family members revealed that p.F464S
segregated with the disease as an
X-linked recessive mutation (Figure 1a).
We did not find any novel mutations
Abbreviations: IFAP, ichthyosis follicularis with atrichia and photophobia; KFSD, keratosis follicularis
spinulosa decalvans; MBTPS2, membrane-bound transcription factor protease, site 2; OS, Olmsted
syndrome; TRPV3, transient receptor potential vanilloid 3
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or rare single nucleotide polymorphisms
or indels in TRPV3, in the gap junction
genes GJB2, GJB3, GJB4, GJB6, or in
DSP (desmoplakin) or JUP (plakoglobin).
MBTPS2 is a zinc metalloprotease
that, along with MBTPS1, mediates
cleavage of signaling proteins involved
in transcriptional responses of cells to
sterols, including SREBPs (Sakai et al.,
1998), and of components of the unfolded
protein response such as ATF6 (Ye
et al., 2000).
MBTPS2 mutations have been linked
to three skin diseases: ichthyosis folli-
cularis with atrichia and photophobia
(IFAP) syndrome (Oeffner et al., 2009;
Ding et al., 2010; Tang et al., 2011),
keratosis follicularis spinulosa decal-
vans (KFSD) (Aten et al., 2010), and
BRESEK/BRESHECK syndrome (Naiki
et al., 2012), suggesting the specific
position of a disease-associated muta-
tion in MBTPS2 affects the clinical
presentation. In line with the X-linked
inheritance, only male patients presented
with full clinical disease features,
whereas female carriers of MBTPS2
mutations were either phenotypically
normal or showed rather mild and
asymmetric symptoms.
MBTPS2 has a HEIGH motif and an
LDG (amino acids 466–468) motif,
which are predicted to coordinate the
zinc atom in the active site of the
enzyme (Zelenski et al., 1999). In vitro
functional investigations with MBTPS2
skin disease mutants revealed de-
creased sterol responsiveness and were
predicted to deplete protease activity
(Oeffner et al., 2009; Aten et al., 2010),
with the mutants p.R429H and p.F475S
having the most profound effect (Oeff-
ner et al., 2009). p.R429H and p.F475S
are also associated with the most severe
disease phenotypes, and it is hypothe-
sized that this is because of their close
proximity to the LDG motif (Oeffner
et al., 2009; Naiki et al., 2012). p.F464S
discovered in this study is only two
codons from the LDG motif, and thus is
likely to have a significantly detrimental
effect on MBTPS2 function and would
reflect the severity of symptoms in the
OS patients.
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Figure 1. Clinical features of Olmsted syndrome (OS) and family pedigree. (a) Pedigree of the OS family.
The MBTPS2 mutation p.F464S segregates with disease with unaffected females (I-1 and II-2) being
carriers, both probands (II-1 and III-2) being hemizygous for the mutation, and the unaffected male (III-1)
being wild type (WT). (b–d) Clinical features of OS in the probands II-1 (b, d) and III-2 (c). The clinical
features included alopecia universalis and sharply marginated, thick, verrucous, and erythematous
hyperkeratotic plaques around all of the body orifices and on the hands and feet. Panel c shows the
periorificial plaques around the mouth after treatment. MBTPS2, membrane-bound transcription factor
protease, site 2.
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Figure 2. Sequencing results and immunohistochemical staining. (a) c.1391T4C (p.F464S) in MBTPS2. Normal (wild-type) sequence (top) compared
with a female carrier (middle) and male proband (bottom). (b) ClustalW multiple sequence alignments of MBTPS2. This indicates that the phenylalanine residue
at codon 464 is highly conserved. (c) Immunohistochemistry of MBTPS2. In normal male skin, MBTPS2 is expressed mainly in the upper granular layer,
whereas in OS (Olmsted syndrome) skin it is expressed throughout the epidermis. Bar¼20 mm. MBTPS2, membrane-bound transcription factor protease, site 2.
572 Journal of Investigative Dermatology (2013), Volume 133
A Haghighi et al.
MBTPS2 Mutation in Olmsted Syndrome
Immunohistochemical staining indi-
cated that MBTPS2 is mainly expressed
in the upper granular layer in normal
skin, as previously shown (Aten et al.,
2010); however, in OS skin, MBTPS2
was expressed throughout the epi-
dermis (Figure 2c). There was no
apparent difference in MBTPS2 locali-
zation in the skin of a KFSD patient with
the p.N508S mutation (Aten et al.,
2010). It is unclear why this is but it
may be because of differences in
processing of the mutants in the two
diseases.
In summary, we demonstrate a novel
association between an MBTPS2 muta-
tion and an X-linked form of OS. This
expands the number of disorders linked
to MBTPS2 mutations and reveals clin-
ical heterogeneity associated with dif-
ferent MBTPS2 mutations.
Written, informed consent was
obtained from all family members or
their legal guardians. This study was
approved by the South East NHS
Research Ethics Committee and was
performed according to the Declaration
of Helsinki Principles.
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and Other Skin Diseases
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TO THE EDITOR
The inherited ichthyoses are a large and
genetically heterogeneous group of
Mendelian disorders of cornification,
characterized by scaling and/or hyper-
keratosis over the majority of the
integument (Oji et al., 2010). The two
main nonsyndromic ichthyosis groups
are autosomal recessive congenital
ichthyosis (ARCI), encompassing lamel-
lar ichthyosis (LI), congenital ichthyosi-
form erythroderma (CIE), and harlequin
ichthyosis (HI), in which patients are
Abbreviations: ARCI, autosomal recessive congenital ichthyosis; CIE, congenital ichthyosiform
erythroderma; HI, harlequin ichthyosis; KPI, keratinopathic ichthyosis; LI, lamellar ichthyosis; NGS, next-
generation sequencing; SPPK, striate palmoplantar keratoderma; SNP, single-nucleotide polymorphism
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